Browse > Article

Anticancer Effects of the Isoflavone Extract from Chungkukjang via Cell Cycle Arrest and Apoptosis in MDA-MB-453 Cells  

Shin, Jin Young (College of Pharmacy, Sookmyung Women's University)
Kim, Taehee (College of Pharmacy, Sookmyung Women's University)
Kim, An Keun (College of Pharmacy, Sookmyung Women's University)
Publication Information
YAKHAK HOEJI / v.58, no.1, 2014 , pp. 33-39 More about this Journal
Abstract
The objective of this study is to evaluate the anticancer effects of the isoflavone extract from Chungkukjang in human breast cancer, MDA-MB-453 cells. For this study, MDA-MB-453 cells were treated with 12.5, 25, and $50{\mu}g$ isoflavone extract for 24, 48, and 72 hr. Cell proliferations were decreased in a time- and dose-dependent manner. Reduced cell proliferation was suspected by apoptosis or cell cycle arrest. Therefore, after treatment of $50{\mu}g$ isoflavone extract, apoptotic cells were investigated by annexin V staining. The results indicated that isoflavone extract increased the number of early apoptotic cells compared with control. Cleaved PARP was also increased. Next, we investigated the cell cycle and related proteins. The isoflavone extract leads to cell cycle arrest at the G2/M phase. Moreover isoflavone extract had influenced cell cycle relate proteins such as cyclin B1, cyclin A, and p21. These results suggest that isoflavone extract from Chungkukjang induce apoptosis and cell cycle arrest at G2/M phase via regulation of cell cycle-related proteins in MDA-MB-453 cells.
Keywords
MDA-MB-453; cell cycle arrest; apoptosis; Chungkukjang;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Onozawa, M., Fukuda, K., Ohtani, M., Akaza, H., Sugimura, T. and Wakabayashi, K. : Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Jpn. J. Clin. Oncol. 28, 360 (1998).   DOI   ScienceOn
2 Delhalle, S., Duvoix, A., Schnekenburger, M., Morceau, F., Dicato, M. and Diederich, M. : An introduction to the molecular mechanisms of apoptosis. Ann. N. Y. Acad. Sci. 1010, 1 (2003).   DOI
3 Hong, S. J., Dawson, T. M. and Dawson, V. L. : Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol. Sci. 25, 259 (2004).   DOI   ScienceOn
4 Prez-Roger, I., Ivorra, C., Dez, A., Corts, M. J., Poch, E., Sanz- Gonzlez, S. M. and Andrs, V. : Inhibition of cellular proliferation by drug targeting of cyclin-dependent kinases. Curr. Pharm. Biotechnol. 1, 107 (2000).   DOI
5 O'Connor, P. M. and Kohn, K. W. : A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells? Semin. Cancer Biol. 3, 409 (1992).
6 Zhou, J. R., Mukherjee, P., Gugger, E. T., Tanaka, T., Blackburn, G. L. and Clinton, S. K. : Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res. 58, 5231 (1998).
7 Hickman, J. A. : Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11, 121 (1992).   DOI   ScienceOn
8 El-Kenawi, A. E. and El-Remessy, A. B. : Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br. J. Pharmacol. 170, 712 (2013).   DOI
9 Qu, Z., MacLellan, W. R. and Weiss, J. N. : Dynamics of the cell cycle: checkpoints, sizers, and timers. Biophys. J. 85, 3600 (2003).   DOI   ScienceOn
10 Pines, J. : Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308, 697 (1995).   DOI
11 Hickman, J. A. : Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11, 121 (1992).   DOI   ScienceOn
12 Jin, S., Zhang, Q. Y., Kang, X. M., Wang, J. X. and Zhao, W. H. : Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann. Oncol. 21, 263 (2010).   DOI
13 Choi, E. J. and Kim, G. H. : Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedicine 15, 683 (2008).   DOI   ScienceOn
14 Sergeev, I. N. : Genistein induces Ca2+ -mediated, calpain/ caspase-12-dependent apoptosis in breast cancer cells. Biochem. Biophys. Res. Commun. 321, 462 (2004).   DOI
15 Li, Z., Li, J., Mo, B., Hu, C., Liu, H., Qi, H., Wang, X. and Xu, J. : Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol. In Vitro 22, 1749 (2008).   DOI
16 Zheng, J., Jin, Y. and Row, K. H. : Analysis of isoflavones from Korean and Chinese soybean and processed products by HPLC. J. Korean Chem. Society 49, 349 (2005).   DOI
17 Choi, Y. H., Lim, H., Heo, M. Y., Kwon, D. Y. and Kim, H. P. : Anti-inflammatory activity of the ethanol extract of Chungkukjang, Korean fermented bean: 5-lipoxygenase inhibition. J. Med. Food 11, 539 (2008).   DOI   ScienceOn
18 Kim, N. Y., Song, E. J., Kwon, D. Y., Kim, H. P. and Heo, M. Y. : Antioxidant and antigenotoxic activities of Korean fermented soybean. Food Chem. Toxicol. 46, 1184 (2008).   DOI   ScienceOn
19 Wada, K., Nakamura, K., Tamai, Y., Tsuji, M., Kawachi, T., Hori, A., Takeyama, N., Tanabashi, S., Matsushita, S., Tokimitsu, N. and Nagata, C. : Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int. J. Cancer 13, 952 (2013).
20 Hwang, J. S., Yoo, H. J., Song, H. J., Kim, K. K., Chun, Y. J., Matsui, T. and Kim, H. B. : Inflammation-related signaling pathways implicating TGF$\beta$ are revealed in the expression profiling of MCF7 cell treated with fermented soybean, chungkookjang. Nutr. Cancer 63, 645 (2011).   DOI   ScienceOn
21 Nagata, C. : Factors to consider in the association between soy isoflavone intake and breast cancer risk. J. Epidemiol. 20, 83 (2010).   DOI
22 Messina, M. J., Persky, V., Setchell, K. D. and Barnes, S. : Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21, 133 (1994).   DOI   ScienceOn
23 Messina, M. and Messina, V. : Increasing use of soyfoods and their potential role in cancer prevention. J. Am. Diet Assoc. 91, 836 (1991).
24 Molteni, A., Brizio-Molteni, L. and Persky, V. : In vitro hormonal effects of soybean isoflavones. J. Nutr. 125, 751S (1995).
25 Kennedy, A. R. : The evidence for soybean products as cancer preventive agents. J. Nutr. 125, 733S (1995).
26 Knight, D. C. and Eden, J. A. : A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 87, 897 (1996).
27 Kurzer, M. S. and Xu, X. : Dietary phytoestrogens. Annu. Rev. Nutr. 17, 353 (1997).   DOI   ScienceOn
28 Kim, N. Y., Song, E. J., Kwon, D. Y., Kim, H. P. and Heo, M. Y. : Antioxidant and antigenotoxic activities of Korean fermented soybean. Food Chem. Toxicol. 46, 1184 (2008).   DOI   ScienceOn
29 Lewis, C. : A review of the use of chemoprotectants in cancer chemotherapy. Drug Saf. 11, 153 (1994).   DOI
30 Kao, T. H., Wu, W. M., Hung, C. F., Wu, W. B. and Chen, B. H. : Anti-inflammatory effects of isoflavone powder produced from soybean cake. J. Agric. Food Chem. 55, 11068 (2007).   DOI   ScienceOn
31 Gottesman, M. M. : Report of a meeting: molecular basis of cancer therapy. J. Natl. Cancer Inst. 86, 1277 (1994).   DOI